Unicharm Co. (OTCMKTS:UNICY - Get Free Report) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 2,200 shares, a decrease of 96.5% from the September 30th total of 63,400 shares. Based on an average daily volume of 231,800 shares, the days-to-cover ratio is currently 0.0 days.
Unicharm Stock Performance
Shares of Unicharm stock traded down $0.03 during trading hours on Friday, reaching $6.42. The company's stock had a trading volume of 145,522 shares, compared to its average volume of 158,742. The company has a market capitalization of $18.95 billion, a P/E ratio of 32.25 and a beta of 0.22. The stock's fifty day simple moving average is $6.96 and its two-hundred day simple moving average is $6.61. Unicharm has a one year low of $5.55 and a one year high of $7.53.
Unicharm (OTCMKTS:UNICY - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $1.61 billion for the quarter. Unicharm had a net margin of 9.35% and a return on equity of 11.21%. As a group, research analysts forecast that Unicharm will post 0.21 earnings per share for the current year.
Unicharm Company Profile
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
Featured Stories
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
